{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 9, "transaction_limit": 160, "filters": {"q": "", "ticker": "RPRX", "sector": "", "industry": "", "side": "", "start": "2026-06-19", "end": "2026-08-03"}, "summary": {"total": 9, "acquisition_count": 1, "disposal_count": 8, "acquisition_value": 37481.4622, "acquisition_value_label": "$37.5K", "disposal_value": 16515268.3066, "disposal_value_label": "$16.5M", "net_value": -16477786.8444, "net_value_label": "$-16.5M", "flow_tone": "negative", "largest_value_label": "$6.4M", "top_sector": "Healthcare", "window_label": "19 Jun 2026 to 03 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 9, "value": "16552749.7688", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$16.6M"}], "days": [{"transaction_date": "2026-06-23", "acquisitions": 0, "disposals": 2, "total": 2, "bar_width": 40.0}, {"transaction_date": "2026-06-24", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 20.0}, {"transaction_date": "2026-06-30", "acquisitions": 1, "disposals": 4, "total": 5, "bar_width": 100.0}, {"transaction_date": "2026-07-01", "acquisitions": 0, "disposals": 1, "total": 1, "bar_width": 20.0}], "side_mix": {"acquisitions": 1, "disposals": 8, "acquisition_share": 11.1, "disposal_share": 88.9}}, "company_flows": [{"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "acquisitions": 1, "disposals": 8, "acquired_value": 37481.4622, "acquired_value_label": "$37.5K", "disposed_value": 16515268.3066, "disposed_value_label": "$16.5M", "net_value": -16477786.8444, "net_value_label": "$-16.5M", "acquisition_share": 11.1, "disposal_share": 88.9, "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}], "company_overview": [{"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-01", "filings": 9, "acquisitions": 1, "disposals": 8, "acquired_value": 37481.4622, "acquired_value_label": "$37.5K", "disposed_value": 16515268.3066, "disposed_value_label": "$16.5M", "net_value": -16477786.8444, "net_value_label": "$-16.5M", "acquisition_share": 11.1, "disposal_share": 88.9, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}], "transactions": [{"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-01", "executive": "URIST, MARSHALL", "executive_title": "EVP, Research & Investments", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 9099.0, "share_price": 55.8802, "transaction_value": 508453.9398, "fetched_at": "2026-07-21T21:54:01.402152+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "HITE, CHRISTOPHER", "executive_title": "EVP & Chairman, Partnering", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 97446.0, "share_price": 56.5028, "transaction_value": 5505971.8488, "fetched_at": "2026-07-21T21:54:01.407136+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "HITE, CHRISTOPHER", "executive_title": "EVP & Chairman, Partnering", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 29400.0, "share_price": 56.4423, "transaction_value": 1659403.62, "fetched_at": "2026-07-21T21:54:01.413229+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "HITE, CHRISTOPHER", "executive_title": "EVP & Chairman, Partnering", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 2554.0, "share_price": 57.1031, "transaction_value": 145841.3174, "fetched_at": "2026-07-21T21:54:01.409356+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "BASSLER, BONNIE L", "executive_title": "Director", "security_type": "Class A Ordinary Shares", "side_code": "A", "side": "Acquisition", "shares": 689.0, "share_price": 54.3998, "transaction_value": 37481.4622, "fetched_at": "2026-07-21T21:54:01.411148+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-30", "executive": "HITE, CHRISTOPHER", "executive_title": "EVP & Chairman, Partnering", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 600.0, "share_price": 57.09, "transaction_value": 34254.0, "fetched_at": "2026-07-21T21:54:01.414886+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-24", "executive": "URIST, MARSHALL", "executive_title": "EVP, Research & Investments", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 9098.0, "share_price": 55.1843, "transaction_value": 502066.7614, "fetched_at": "2026-07-14T21:49:25.073944+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "HITE, CHRISTOPHER", "executive_title": "EVP & Chairman, Partnering", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 117592.0, "share_price": 54.4746, "transaction_value": 6405777.1632, "fetched_at": "2026-07-14T21:49:25.077101+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}, {"symbol": "RPRX", "name": "Royalty Pharma\u00a0Plc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "HITE, CHRISTOPHER", "executive_title": "EVP & Chairman, Partnering", "security_type": "Class A Ordinary Shares", "side_code": "D", "side": "Disposal", "shares": 32408.0, "share_price": 54.107, "transaction_value": 1753499.656, "fetched_at": "2026-07-14T21:49:25.079996+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/rprx/", "research_links": {"chart": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/", "report": "/terminal/ae5411df-3593-4a38-856b-8baefeb95722/report/", "factor": "/factors/ticker/ae5411df-3593-4a38-856b-8baefeb95722/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}